Article Text
Editorial
Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues
Statistics from Altmetric.com
Footnotes
-
Competing interests: In the past 2 years, clinical research support has been received from Genentech, Eyetech/OSI Pharmaceuticals and Alcon Laboratories. Dr Rosenfeld has participated in scientific advisory boards on behalf of Genentech, Novartis Ophthalmics, Allergan, BioAxone, PDL Biopharmaceuticals, Tanox, Jerini and Genaera. He also participates in the Genentech speakers’ bureau.